Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 16:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
1.37 USD -5.52% Intraday chart for NKGen Biotech, Inc. -12.74% -83.49%
06-03 NKGen Biotech, Inc. To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
05-23 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting CI
c0.4QQ-BMrG0mdDMO_VDFwIEDrqenHrleuYcLTx9lHSg6c.tEZJQKWi4TQQA57mXDtiX0neGD7YrILAM-PJtwuU25KAQkRhhZKEVHFftg~28fad41ae69b939dd4328c8427b79946
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.
  6. News Chart